Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Gulf Coast Pain Institute Gets Restructured

The transaction builds upon BGL’s market leadership position in advising physician practices and related ancillary services. GCPI represents the third transaction for BGL’s Healthcare & Life Sciences investment banking practice in the pain management specialty in less than two years. Founded in 2013, Gulf Coast Pain Institute is the leading interventional pain management practice in…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

The transaction builds upon BGL’s market leadership position in advising physician practices and related ancillary services. GCPI represents the third transaction for BGL’s Healthcare & Life Sciences investment banking practice in the pain management specialty in less than two years.

Founded in 2013, Gulf Coast Pain Institute is the leading interventional pain management practice in northwest Florida. Gulf Coast Pain Institute provides a comprehensive suite of pain management and ancillary services including interventional and non-interventional procedures, physical therapy, chiropractic services, laboratory testing, durable medical equipment distribution, and pharmacy services.

Gulf Coast Pain Institute’s provider staff includes seven pain management physicians, two chiropractic physicians, two physical therapists, three physician assistants, and five advanced registered nurse practitioners throughout its 11 locations.

Read the full article here

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

"Biotech in the Balance" - Dr. Jeremy Levin, author and Chair of Ovid Therapeutics

The article 'Biotech in the Balance' features insights from Dr. Jeremy Levin, the Chair of Ovid Therapeutics. It explores the current state and future prospects of the biotech industry in balancing innovation and regulation.

  • 01Dr. Jeremy Levin is the Chair of Ovid Therapeutics.
  • 02Balancing innovation and regulation is a key challenge in the biotech industry.

Aug 8, 2026

AI Shouldn't Replace Physicists - It Should Give Them Time Back

AI Shouldn't Replace Physicists - It Should Give Them Time Back

The article discusses the role of AI in the healthcare industry, emphasizing that AI should enhance the efficiency of physicists rather than replace them. TheraPanacea, founded by mathematician Nico Asperagus, focuses on developing AI platforms to improve efficiency and standardization in healthcare. The aim is for AI to handle routine tasks, allowing professionals more time for complex problem-solving.

  • 01AI should be used to enhance the efficiency of physicists rather than replace them.
  • 02TheraPanacea develops AI platforms for improving efficiency and standardization in healthcare.
  • 03AI platforms aim to manage routine tasks, allowing professionals more time for complex analysis.

Aug 7, 2026

FDA-authorized digital medical devices have grown substantially over two decades, but regulatory databases still can't track them

FDA-authorized digital medical devices have grown substantially over two decades, but regulatory databases still can't track them

A Nature study reveals a significant increase in FDA-authorized digital medical devices over the past two decades. However, the FDA's regulatory databases are still unable to specify which of these devices contain software. This gap points to the need for improved database capabilities to better track digital medical devices.

  • 01FDA-authorized digital medical devices have increased significantly over the last 20 years.
  • 02The current FDA regulatory databases lack the capability to identify devices that include software.

Aug 5, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512